Nilesh Patel, DPM
Foot & Ankle Surgery · Austin, TXNPI 1851656318
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 78.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $2,557 and has fallen 81.0% since, to $486 in 2025.
Across 147 payments — averaging $57.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Smith+Nephew$1K
- Paragon 28, Inc.$198
- Medtronic$187
- Bone Support Inc.$129
- Johnson & Johnson$92
- plus $181 from 6 others
What the payments were for
- Travel & lodging$6428%
- Food & beverage$7,86992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 94 | $6,717 |
| Smith+Nephew | 27 | $1,008 |
| Paragon 28, Inc. | 2 | $198 |
| Medtronic | 2 | $187 |
| Bone Support Inc. | 1 | $129 |
| Johnson & Johnson | 2 | $92 |
| Organogenesis Inc. | 11 | $79 |
| Arbor Pharmaceuticals, Inc. | 3 | $37 |
| Bioventus LLC | 2 | $33 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $13 |
| GRT US Holding, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$863
- VARIAX$572
- PROstep$404
- PROSTEP MICA$284
- ALLOWRAP$261
- Portfolio$149
- NONE$146
- Grafix$130
- CERAMENTBONE VOID FILLER$129
- CERAMENT G$129
- AUGMENT INJECTABLE$123
- Grafix PRIME$122
- Grafix CORE$122
- Grafix XC$122
- Grafix PL PRIME$122
- Stravix$122
- ORTHOLOC 2 LAPIFUSE$117
- ALLOGRAFT$104
- NEW PRODUCT DEVELOPMENT$101
How this compares
$8,511 in reported general payments places this provider in the 70th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 42 | $595 |
| Duloxetine Hcl | 14 | $312 |
| Cephalexin | 24 | $142 |
| Allopurinol | 20 | $128 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Austin
- Mark DaltonAustin$1.9M
- Andrew EbertAustin$82K
- Pedro CosculluelaAustin$69K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.